Endoscopic Sleeve Gastroplasty / Endoscopic Sleeve Gastroplasty
1 other identifier
observational
75
1 country
1
Brief Summary
This will be a prospective, registry study of an investigational procedure for at least 12 standard of care visits up to 1 year after subject consents for study. Subjects will be enrolled between 8/1/2018 and 8/1/2023. Subjects will undergo a clinically indicated endoscopic procedure and subsequent follow up clinic visits as part of their standard medical care. Disclaimer: To undergo the procedure there is an out of pocket expense for $9000.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Aug 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 27, 2018
CompletedFirst Submitted
Initial submission to the registry
August 12, 2019
CompletedFirst Posted
Study publicly available on registry
November 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 9, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 9, 2026
CompletedMarch 23, 2026
February 1, 2026
7.5 years
August 12, 2019
March 19, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Weight loss
Percentage of total and excess weight loss at 30 days, 3 months, 6 months and 12 months after procedure.
8/1/2018 and 8/1/2023
Secondary Outcomes (1)
Documentation of safety
8/1/2018 and 8/1/2023
Interventions
510(k) summary K081853 dated June 26, 2008, Endoscopic Sleeve Gastroplasty lecture, Methodist Dallas Medical Center Endobariatric Pathway \& Endoscopic Sleeve Gastroplasty Procedure Description
Eligibility Criteria
All patients who undergo bariatric procedures at Methodist Dallas Medical Center
You may qualify if:
- Age 18 years or older
- Able to comprehend and provided written informed consent
- Willing to comply with the substantial lifelong dietary restrictions required by the procedure
- History of failure with non-surgical weight-loss methods
- Willing to follow protocol requirements, including providing informed consent, routine follow-up schedule, completing laboratory tests, and completing diet counseling
- Women of childbearing potential ( not post-menopausal or surgically sterilized) must agree to use adequate birth control methods
You may not qualify if:
- Below 18 years of age
- Prohibitive anesthetic risk
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Methodist Dallas Medical Center
Dallas, Texas, 75023, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Prashant Kedia, MD
The Methodist Hospital Research Institute
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 12, 2019
First Posted
November 23, 2020
Study Start
August 27, 2018
Primary Completion
February 9, 2026
Study Completion
March 9, 2026
Last Updated
March 23, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share